Hello, everyone!
Would anyone be available to grade my essay and provide feedback?
Sajjad1994, would you mind reviewing my essay on your GMAT AWA auto-grader? By the way, is there any way I can have access to a free auto-grader?
I read some of the articles recommended on this forum, but this is my very first attempt!
Thanks in advance!
____________
In an article from a consumer-products magazine, it was argued that people who need milder nonprescription medication for the relief of excess stomach acid should opt for Acid-Ease rather than Pepticaid since Acid-Ease’s full-strength prescription had 76 million more medical prescriptions than Pepticaid’s. Stated in this way, the argument fails to mention several key factors, based on which it could be evaluated. The conclusion of the argument relies on assumptions, for which there is no clear evidence. Therefore, the argument is substantially flawed and unconvincing.
First of all, the argument readily assumes that full-strength Acid-Ease is better than full-strength Pepticaid because the former was prescribed more often by doctors. However, this statement is a stretch, as the number of times more a given drug is prescribed to detriment of another does not necessarily translate into the former being better than the latter. To argue this, the argument should have drawn a clear comparison between the effectiveness and potential side effects of each drug, for example. Furthermore, the argument fails to consider other explanations for the discrepancy in the number of prescriptions. It is plausible that full-strength Acid-Ease is not an effective medicine for the treatment of excess stomach acid and needs to be used in higher dosage. It could also be that it is cheaper in contrast to Pepticaid, which might make it the preferred drug by doctors. The argument could have been much clearer if it explicitly stated that full-strength Acid Ease was better than full-strength Pepticaid because of one of the aforementioned reasons and not simply because it was prescribed more.
Secondly, the argument considers that, given that the full-strength form of Acid-Ease is better than the equivalent Pepticaid, the milder nonprescription form of Acid-Ease will be more effective than that of Pepticaid. This is again a very weak and unsupported claim as the argument does not provide any correlation between the effectiveness of milder and full-strength forms of both drugs. The argument failed to provide any guarantee that milder Acid-Ease will perform better than milder Pepticaid, despite how well their full-strength forms work. What if the milder forms of both drugs have different concentrations of the active principle? Would they be equally effective? If the argument had provided evidence that the milder form of Acid-Ease was more effective than that of Pepticaid then it would have been significantly more convincing.
Finally, the argument restricts alternatives to consumers looking for milder nonprescription medication to Pepticaid and Acid-Ease. The fact that these are two of the best-selling brands of full-strength prescription medication for the relief of excess stomach acid does not provide any guarantee that it will be the same for milder options. The argument should have provided evidence about the performance of these brands’ milder options against equivalents from other brands. Without convincing answers to these questions, one is left with the impression that the claim is more of wishful thinking rather than substantiative evidence.
In conclusion, the argument is flawed for the above-mentioned reasons and is therefore unconvincing. It could be considerably strengthened if the author clearly mentioned all the relevant facts about the nonprescription forms of Acid-Ease, Pepticaid, and other alternatives. To assess the merits of a certain situation, it is essential to have full knowledge of all contributing factors. Without this information, the argument remains unsubstantiated and open to debate.